Cargando…
PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer
Aims: PARK2 mutation is originally associated with the progression of Parkinson's disease. In recent years, PARK2 has been reported as a tumor suppressor gene in various cancers, including lung cancer. However, the biological functions and potential molecular mechanisms of PARK2 in non-small ce...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716169/ https://www.ncbi.nlm.nih.gov/pubmed/31508359 http://dx.doi.org/10.3389/fonc.2019.00790 |